Economic challenges of oncological diseases’ pharmacotherapy
نویسندگان
چکیده
منابع مشابه
Rheumatic and oncological diseases – common challenges
The progress of medicine leads to the creation of new medical specialties. Such is the case of internal medicine, from which, among others, rheumatology, geriatrics, cardiology and pulmonology developed. Dynamic progress of oncology and of its main specialties – oncological surgery, radiotherapy and clinical oncology (oncological chemotherapy) – led, on one hand to the emergence of the new spec...
متن کاملPlatelet Septic Transfusion Reactions in Patients With Hemato-Oncological Diseases
Background & Objective: Bacterial, contamination of blood components are a significant risk for transfusion reactions. Inherently, platelet concentrates (PCs) are vulnerable to bacterial contamination, due to the storage condition of processed PCs at room temperature, which provide very suitable conditions for the proliferation of microorganisms....
متن کاملRegister of Oncological Diseases in Canton Sarajevo
CONFLICT OF INTEREST NONE DECLARED. SUMMARY The register of oncological diseases in Canton Sarajevo is important as it can be used to track and improve healthcare, especially in older age groups. The oncological registers are a way of recording data, suitable as a source of indicators. In the analyzed register, 1124 new cases of malignancy were recorded. There are slightly more malignant dise...
متن کاملChallenges in the Pharmacotherapy of Urogenital Disorders
Although some urogenital drugs such as tamsulosin or tolterodine have reached blockbuster status, the pharmacotherapy of urogenital disorders has been lagging behind many other therapeutic areas for a long time. Malformations and trauma of the urogenital tract are a clear domain of surgery, and malignant urogenital disease has more in common with malignancies of other tissues than with other ur...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology
سال: 2020
ISSN: 2070-4933,2070-4909
DOI: 10.17749/2070-4909.2020.13.1.64-70